ŞANLIOĞLU, S. Et Al. TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer. 13th Annual Congress of European Society of Gene Therapy , (Czech Republic), 22.

ŞANLIOĞLU, S., CIFTCIOGLU, A., ŞANLIOĞLU, A. D., Lüleci, G., KÖKSAL, İ. T., BAYKARA, M., ... BAŞSORGUN, C. İ. TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer . 13th Annual Congress of European Society of Gene Therapy (pp.22). , Czech Republic

ŞANLIOĞLU, SALİH Et Al. "TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer," 13th Annual Congress of European Society of Gene Therapy, Czech Republic,

ŞANLIOĞLU, SALİH Et Al. "TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer." 13th Annual Congress of European Society of Gene Therapy , Czech Republic, pp.22

ŞANLIOĞLU, S. Et Al. . "TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer." 13th Annual Congress of European Society of Gene Therapy , Czech Republic, p.22.

@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU Et Al. }, title={TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer}, congress name={13th Annual Congress of European Society of Gene Therapy}, city={}, country={Czech Republic}, year={0}, pages={22} }